Previous Article | Next Article ![]()
Journal of Clinical Microbiology, July 2001, p. 2466-2476, Vol. 39, No. 7
Corixa Corporation1
and Infectious Disease Research
Institute,3 Seattle, Washington 98104;
University of Washington, Department of
Pathobiology, Seattle, Washington 981954; and
Department of Laboratory Medicine and Pathology, Mayo
Foundation, Rochester, Minnesota 559052
Received 31 October 2000/Returned for modification 28 January
2001/Accepted 8 April 2001
A panel of seven recombinant antigens, derived from
Ehrlichia phagocytophila (the agent of human
granulocytic ehrlichiosis), was evaluated by class-specific
enzyme-linked immunosorbent assays (ELISAs) for utility in the
diagnosis of the infection. Fourteen genomic fragments, obtained by
serologic expression screening, contained open reading frames (ORFs)
encoding 16 immunodominant antigens. Eleven of these antigens were
members of the major surface protein (MSP) multigene family.
Alignment of their predicted protein sequences revealed a pattern of
conserved sequences, which contained short direct repeats, flanking a
variable region. In addition, two genomic clones contained two and
three MSP ORFs, respectively, indicating that these genes are clustered
in tandem copies. The implications for this pattern of both genomic and
protein arrangements in antigenic variations of MSPs and in their
utilities in a diagnostic assay are discussed. In addition to two MSP
recombinant antigens (rHGE-1 and -3) and a fusion protein of these
antigens (rErf-1), five further recombinants were evaluated by ELISA.
Two of these antigens (rHGE-14 and -15) were novel, while a third
(rHGE-2), with no known function, has been described. The final two
recombinant antigens (rHGE-9 and -17) represent overlapping segments of
the ankyrin gene (ank). The addition of rHGE-9 ELISA data
resulted in the detection of 78% (21 of 27) of acute-phase
sera. When serologic data for all recombinants are combined,
96.2% (26 of 27) of convalescent-phase patient serum samples and
85.2% (23 of 27) of acute-phase patient serum samples are detected,
indicating the potential of these antigens for use in the development
of a rapid serologic assay for the detection of E.
phagocytophila infection.
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.7.2466-2476.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Serodiagnosis of Human Granulocytic Ehrlichiosis by Using
Novel Combinations of Immunoreactive Recombinant Proteins
*
Corresponding author. Mailing address: Corixa
Corporation, 1124 Columbia St., Suite 200, Seattle, WA 98104. Phone:
(206) 754-5797 or (206) 754-5879. Fax: (206) 754-5715. E-mail for
Michael J. Lodes: lodes{at}corixa.com. E-mail for David H. Persing: persing{at}corixa.com.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|